iFast
Diagnostics startup made investor-ready
Pitching a world-changing diagnostic in a high-stakes regulated category needs language decision-makers trust. No hype. No shortcuts. Just clarity.
What we delivered and how it worked
An investor deck, sales brochure and participation campaign that defined the real diagnostic bottleneck, showed exactly where iFAST fits in clinical workflows, and proved why faster results lead to safer decisions, without hype or oversimplification.
The Impact
- Supported a $6.5M Seed round led by KHP Ventures
- Sparked boardroom/president-level conversations
- Positioned iFAST as clearly distinct in a crowded, cautious market
Fluro doesn’t oversell science. We make it understood, trusted, and taken seriously.
$6.5M
Seed Round Supported
